This week has seen important developments in the marijuana industry, covering legislative changes, industry shifts, and new research findings. Here are the top 10 marijuana news stories you need to know as of November 15, 2024:
-
Trump's Attorney General Nominee Matt Gaetz Sparks Cannabis Industry Optimism President-elect Donald Trump's nomination of Matt Gaetz for attorney general has generated excitement within the cannabis industry due to Gaetz's strong support for marijuana legalization. However, skepticism among GOP senators raises doubts about his confirmation prospects. MarketWatch
-
Study Highlights Potential Genetic Risks of Marijuana Use New research indicates that cannabis is a "genotoxic" substance, capable of damaging genetic information within cells. This damage may lead to DNA mutations, accelerated aging, and increased cancer risk, with potential implications for future generations. New York Post
-
Joe Rogan Discusses Kamala Harris's Stance on Marijuana Legalization Podcaster Joe Rogan revealed that Vice President Kamala Harris's campaign team requested to avoid discussing marijuana legalization during a proposed interview, fearing backlash from progressive supporters. The interview ultimately did not occur. New York Post
-
Illinois Introduces THC-Infused Giardiniera for the Holidays Chicago's J.P. Graziano and nuEra have collaborated to create "GiardinuEra," a cannabis-infused version of the traditional spicy pickled condiment, giardiniera. Each 4-ounce jar contains 25mg of THC and is available at select dispensaries in Illinois. Eater Chicago
-
2024 Marks a Pivotal Year for U.S. Cannabis Industry The U.S. cannabis industry experienced significant milestones in 2024, including the DEA's decision to reclassify cannabis from Schedule I to Schedule III. This move is expected to alleviate industry challenges and align federal policies with state-level legalization efforts.Reuters
-
Cannabis Shows Promise in Alleviating Dementia Symptoms Emerging research suggests that cannabis may help reduce anxiety, agitation, and pain in dementia patients, while improving sleep, appetite, and mood. However, potential risks, such as increased fall incidents, warrant cautious consideration. The Wall Street Journal
-
Florida's Recreational Marijuana Legalization Referendum Fails Florida's Amendment 3, which sought to legalize recreational marijuana, did not achieve the required 60% supermajority, garnering just under 56% support. Governor Ron DeSantis, who opposed the measure, viewed the outcome as a victory. New York Post
-
Concerns Raised Over Mold Contamination in Legal Marijuana An analysis revealed that some state-approved marijuana contains dangerous mold, potentially due to underreporting by testing labs. This raises health concerns for consumers and highlights the need for stricter testing protocols. The Wall Street Journal
-
Marijuana Legalization Faces Challenges in Conservative States Despite growing national acceptance, marijuana legalization efforts encounter resistance in conservative states, creating a "red wall" that continues to criminalize cannabis consumers. Marijuana Moment
-
2024 Election Results Influence Employer Drug Policies Recent election outcomes on marijuana and psychedelic laws are prompting employers to reassess workplace drug policies to ensure compliance with evolving state regulations. Forbes
These stories illustrate the ongoing evolution of the marijuana industry, highlighting key shifts in public opinion, legislation, and market trends. Stay tuned as the cannabis landscape continues to change rapidly across the U.S.